JO
PALI icon

John Overdeck’s Palisade Bio PALI Stock Holding History

John Overdeck’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Buy
126,602
+98,962
+358% +$195K ﹤0.01% 4611
2026
Q1 		$48.4K Hold
27,640
– – ﹤0.01% 4455
2025
Q4 		$65K Buy
+27,640
New +$53.1K ﹤0.01% 3902
2023
Q1 		– Sell
-693
Closed -$54.1K – 3147
2022
Q4 		$54.1K Buy
693
+586
+548% +$34K ﹤0.01% 2581
2022
Q3 		$8K Buy
+107
New +$22.7K ﹤0.01% 2419
2022
Q2 		– Sell
-29
Closed -$23K – 2833
2022
Q1 		$23K Buy
29
+10
+53% +$8.08K ﹤0.01% 2522
2021
Q4 		$19K Buy
+19
New +$33.2K ﹤0.01% 4174

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

John Overdeck's PALI Position: Q2 2026 in Review

John Overdeck increased its Palisade Bio (PALI) stake by 358% in Q2 2026, buying an estimated $195K and bringing the position to 126,602 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #4611.

John Overdeck first reported a position in PALI in Q4 2021 and has held it in 7 quarters since. 123 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • John Overdeck held 126,602 shares of Palisade Bio worth $265K as of Q2 2026.
  • John Overdeck bought 98,962 Palisade Bio shares in Q2 2026, an estimated $195K.
  • Palisade Bio made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4611 holding.
  • John Overdeck first reported a position in Palisade Bio in Q4 2021 and has held it in 7 quarters since.
  • 123 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.